Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: a case–control study
Abstract Objective This study was to determine and compare the prevalences of polypharmacy and comorbidities in patients aged 50 years or older with those patients younger than 50 years in a Mexican population. Results One hundred and twenty-five patients were enrolled, 60 (48%) were aged 50 years o...
Main Authors: | José Antonio Mata-Marín, Moisés Hermilo Martínez-Osio, Carla I. Arroyo-Anduiza, María de los Ángeles Berrospe-Silva, Alberto Chaparro-Sánchez, Itzel Cruz-Grajales, Javier Enrique Cruz-Herrera, Luis Antonio Uribe-Noguez, Jesus E. Gaytán-Martínez, Medardo Jerónimo-Morales |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-019-4576-6 |
Similar Items
-
Polypharmacy and comorbidity status in the treatment of type 2 diabetic patients attending a tertiary care hospital: An observational and questionnaire-based study
by: Rania Indu, et al.
Published: (2018-01-01) -
The burden of polypharmacy and pattern of comorbidities among chronic kidney disease patients in clinical practice
by: Olumuyiwa John Fasipe, et al.
Published: (2018-01-01) -
What is polypharmacy? A systematic review of definitions
by: Nashwa Masnoon, et al.
Published: (2017-10-01) -
POLYPHARMACY: RESPONSE
by: S. O. Kluchnikov
Published: (2015-08-01) -
Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner′s perspective
by: Stanislaw P Stawicki, et al.
Published: (2015-01-01)